C21 Investments Q1 Loss Widens; Going Concern Risk Disclosed as Vireo Acquisition Nears Close
CXXIF sits 58% above its 52-week low of $0.168 on elevated volume (3.4× avg).
Summary
C21 Investments reported a wider Q1 loss and disclosed going concern risk, while confirming the Vireo Growth acquisition is expected to close today.
Key Events · Earnings and Guidance · CXXIF
-
Q1 Net Loss Widens
Net loss was $1.97 million for the three months ended June 30, 2026, versus $0.76 million in the prior-year quarter.
-
Revenue Declines 10.8%
Revenue fell to $7.63 million from $8.55 million, driven by price compression and increased competition in Nevada.
-
Going Concern Risk Disclosed
The company states that changes in federal enforcement priorities could impact its ability to continue as a going concern.
-
Uncertain Tax Position Increases
Uncertain tax position rose to $14.09 million from $13.36 million at March 31, 2026, related to Section 280E.
Analysis · CXXIF · Life Sciences
C21 Investments reported a net loss of $1.97 million for the quarter ended June 30, 2026, compared to a loss of $0.76 million a year earlier, as revenue fell 10.8% to $7.63 million. The company also disclosed going concern language related to federal cannabis enforcement uncertainty and an increased uncertain tax position of $14.09 million. The filing confirms the Vireo Growth acquisition is expected to close on August 21, 2026, which is today's date.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CXXIF was trading at $0.26 on OTC in the Life Sciences sector, with a market capitalization of approximately $57.9M. The 52-week trading range was $0.17 to $0.54. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.